These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16553203)

  • 1. [Cholesterol crystal embolisation in the course of treatment with low-molecular-weight heparins].
    Calotă F; Vîlcea D; Intorcaciu M; Pâirvănescu H; Enache D; Comănescu V; Vasile I; Scurtu S
    Chirurgia (Bucur); 2005; 100(6):605-8. PubMed ID: 16553203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cholesterol crystal embolism during treatment with low-molecular-weight heparin].
    Belenfant X; d'Auzac C; Bariéty J; Jacquot C
    Presse Med; 1997 Sep; 26(26):1236-7. PubMed ID: 9380624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cholesterol crystal embolism].
    Tazi-Mézalek Z; Filali N; Harmouche H; Adnaoui M; Aouni M; Mohattane A; Maaouni A; Berbich A
    Ann Cardiol Angeiol (Paris); 2000 Feb; 49(1):48-59. PubMed ID: 12555320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of low-molecular-weight heparins in pregnancy--how safe are they?
    Deruelle P; Coulon C
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):573-7. PubMed ID: 18007136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Case of cholesterol crystal embolism occurring after treatment of cerebral infarction with urokinase].
    Kimura H; Miyoshi K; Maeda H; Ikeda H; Mitsuiki K; Harada A
    Nihon Jinzo Gakkai Shi; 2004; 46(4):377-81. PubMed ID: 16773802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol crystal embolization demonstrated on GI biopsy.
    Paraf F; Jacquot C; Bloch F; de Montpréville V; Bruneval P
    Am J Gastroenterol; 2001 Dec; 96(12):3301-4. PubMed ID: 11774940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves.
    James AH; Brancazio LR; Gehrig TR; Wang A; Ortel TL
    J Matern Fetal Neonatal Med; 2006 Sep; 19(9):543-9. PubMed ID: 16966122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cholesterol crystal embolisms in adenomatous polyposis coli].
    Paraf F; Bouillot JC; Bruneval P
    Ann Pathol; 1999 Apr; 19(2):135-8. PubMed ID: 10349480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol crystal embolization caused by anticoagulant therapy.
    Cortez AF; Sakuma TH; Lima RB; de Figueiredo WM; Valle Hde A; Tolstoy FA; Coimbra DD; Lupi O
    Int J Dermatol; 2009 Sep; 48(9):989-90. PubMed ID: 19702986
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparin and low-molecular-weight heparin.
    Gray E; Mulloy B; Barrowcliffe TW
    Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke.
    Kiphuth IC; Köhrmann M; Huttner HB; Schellinger PD
    Expert Opin Drug Saf; 2009 Sep; 8(5):585-97. PubMed ID: 19614560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are all low molecular weight heparins equivalent in the management of venous thromboembolism?
    Fareed J; Jeske W; Fareed D; Clark M; Wahi R; Adiguzel C; Hoppensteadt D
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):385-92. PubMed ID: 18815137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low-molecular-weight heparins versus unfractionated heparin for treatment of hemodialysed patients].
    Kes P; Basić-Jukić N; Jurić I
    Lijec Vjesn; 2007; 129(8-9):305-8. PubMed ID: 18198633
    [No Abstract]   [Full Text] [Related]  

  • 14. Early administration of low molecular weight heparin after spontaneous intracerebral hemorrhage. A safety analysis.
    Kiphuth IC; Staykov D; Köhrmann M; Struffert T; Richter G; Bardutzky J; Kollmar R; Mäurer M; Schellinger PD; Hilz MJ; Doerfler A; Schwab S; Huttner HB
    Cerebrovasc Dis; 2009; 27(2):146-50. PubMed ID: 19039218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A cholesterol embolism during heparin treatment].
    López Pardo F; González Barrero A; Serrano Castro V; Andreu Alvarez J; Navarrete Ortega M; Burgos Cornejo J
    Rev Esp Cardiol; 1993 Nov; 46(11):758-60. PubMed ID: 8290779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low molecular weight heparins].
    Schröder F; Weiss T
    Dtsch Med Wochenschr; 2002 Aug; 127(31-32):1645-7. PubMed ID: 12168158
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing the quality of pharmacological treatments from administrative databases: the case of low-molecular-weight heparin after major orthopaedic surgery.
    Gerkens S; Beguin C; Crott R; Closon MC; Horsmans Y
    J Eval Clin Pract; 2008 Aug; 14(4):585-94. PubMed ID: 18462276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of two adverse reactions.
    Smith LA; Harkness M
    Postgrad Med J; 2004 Aug; 80(946):484-6. PubMed ID: 15299161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.
    Tetri S; Hakala J; Juvela S; Saloheimo P; Pyhtinen J; Rusanen H; Savolainen ER; Hillbom M
    Thromb Res; 2008; 123(2):206-12. PubMed ID: 18420258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of unfractionated heparin and low molecular weight heparins in pregnancy.
    Casele HL
    Clin Obstet Gynecol; 2006 Dec; 49(4):895-905. PubMed ID: 17082684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.